Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys.
Progesterone is essential for endometrial receptivity in primates. In studies previously performed using global gene profiling based on microarray technology, attempts have been made to identify changes in gene expression between early luteal-phase and mid-luteal-phase endometria. However, the issue of the putative impact of preimplantation embryo-derived signal in the process of endometrial receptivity was missing in the previous studies. In the present study, an attempt has been made to delineate the transcripts profile in implantation-stage endometrium under combinatorial regulation of progesterone and embryo-derived signal in the rhesus monkey. To this effect, we have compared transcript profiles for 409 known genes between control receptive stage (n=13), and mifepristone-induced desynchronized and non-receptive stage (n=12) monkey endometrial samples collected on days 4 (n=12) and 6 (n=13) after ovulation from mated, potential conception cycles, using cDNA arrays containing sequence-verified clones. Statistical analysis of correlation of estimated transcript abundance between arrays and qRT-PCR for nine selected gene products yielded significant (P<0.05) concordance. Of 409 genes, a total of 40 gene transcripts were seen to be affected, nine gene transcripts in endometrial samples were found to progressively increase between days 4 and 6 following mifepristone treatment, while an additional five genes showed differential expression profile depending on the day after treatment. Additionally, different sets of 12 and 14 gene products showed changes in days 4 and 6 post-ovulation samples respectively. A new cohort of 28 gene products in implantation-stage endometrium was seen to be affected by luteal-phase mifepristone.
Ghosh
D
D
Department of Physiology, All India Institute of Medical Sciences, New Delhi, India. debabrata.ghosh1@gmail.com
Sharkey
A M
AM
Charnock-Jones
D S
DS
Smith
S K
SK
Sengupta
Jayasree
J
D000818:Animals; D010064:Embryo Implantation / Q000187:drug effects*; D004717:Endometrium / Q000378:metabolism*; D005260:Female; D015870:Gene Expression; D020869:Gene Expression Profiling; D006727:Hormone Antagonists / Q000008:administration & dosage* / Q000494:pharmacology; D007150:Immunohistochemistry; D053613:Janus Kinase 1 / Q000032:analysis / Q000378:metabolism; D008183:Luteal Phase; D008253:Macaca mulatta; D015735:Mifepristone / Q000008:administration & dosage* / Q000494:pharmacology; D020411:Oligonucleotide Array Sequence Analysis; D011247:Pregnancy; D011374:Progesterone / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D050796:STAT3 Transcription Factor / Q000032:analysis / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology*
D006727:Hormone Antagonists; D050796:STAT3 Transcription Factor; D015735:Mifepristone; D011374:Progesterone; D053613:Janus Kinase 1